Trial intelligence / Profile preview

Safety and Efficacy of MMR Vaccination in Juvenile Idiopathic Arthritis

NCT00731965Phase 4Completed

Start
May 2008
Primary completion
May 2012
Modality
Live Attenuated Vaccines
Countries
1
01

Overview

A Phase 4 trial of M-M-R II in measles, mumps, rubella. Started May 2008; status: completed.

02

Drugs

M-M-R II
03

Conditions

measlesmumpsrubella

Beyond the preview

Go deeper on NCT00731965.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00731965.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call